Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib Maintenance After Chemoradiation in Stage III NSCLC
NCT00020709Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2001
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Jun 2001; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00020709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020709.